Moderna’s mNEXSPIKE generates strong immune response against LP.8.1 variant in humans
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Maria Soler Nunez appointed as Chief Quality Officer
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Subscribe To Our Newsletter & Stay Updated